Literature DB >> 35182436

Lipidomics profiles in hepatocytes from nonalcoholic steatohepatitis patients differ markedly from in vitro-induced steatotic hepatocytes.

Thomas Kralj1, Raju Khatri2, Kenneth R Brouwer2, Kim L R Brouwer3, Darren J Creek1.   

Abstract

Nonalcoholic steatohepatitis (NASH) is a severe form of liver injury that can be caused by a variety of stimuli and has a significant mortality rate. A common technique to induce in vitro steatosis involves culturing primary human hepatocytes (PHH) in fatty acid-enriched media. This study compared the lipidome of PHH cultured in fatty acid-enriched media to hepatocytes from patients with NASH and healthy controls. Hepatocytes from NASH patients displayed increased total cellular abundance of glycerolipids and phospholipids compared to healthy control hepatocytes. PHH cultured in fatty acid-enriched media demonstrated increased glycerolipids. However, these culture conditions did not induce elevated phospholipid levels. Thus, culturing PHH in fatty acid-enriched media has limited capacity to emulate the environment of hepatocytes in NASH patients.
© 2022 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Entities:  

Keywords:  DILI; in vitro models; lipidomics; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; steatosis

Mesh:

Substances:

Year:  2022        PMID: 35182436      PMCID: PMC9197994          DOI: 10.1002/1873-3468.14318

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   3.864


  22 in total

1.  A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations.

Authors:  Juan C García-Cañaveras; M Teresa Donato; José V Castell; Agustín Lahoz
Journal:  J Proteome Res       Date:  2011-09-06       Impact factor: 4.466

2.  PeakML/mzMatch: a file format, Java library, R library, and tool-chain for mass spectrometry data analysis.

Authors:  Richard A Scheltema; Andris Jankevics; Ritsert C Jansen; Morris A Swertz; Rainer Breitling
Journal:  Anal Chem       Date:  2011-03-14       Impact factor: 6.986

3.  A human hepatocellular in vitro model to investigate steatosis.

Authors:  María José Gómez-Lechón; María Teresa Donato; Alicia Martínez-Romero; Nuria Jiménez; José Vicente Castell; José-Enrique O'Connor
Journal:  Chem Biol Interact       Date:  2006-11-23       Impact factor: 5.192

4.  Biomarkers of NAFLD progression: a lipidomics approach to an epidemic.

Authors:  D Lee Gorden; David S Myers; Pavlina T Ivanova; Eoin Fahy; Mano R Maurya; Shakti Gupta; Jun Min; Nathanael J Spann; Jeffrey G McDonald; Samuel L Kelly; Jingjing Duan; M Cameron Sullards; Thomas J Leiker; Robert M Barkley; Oswald Quehenberger; Aaron M Armando; Stephen B Milne; Thomas P Mathews; Michelle D Armstrong; Chijun Li; Willie V Melvin; Ronald H Clements; M Kay Washington; Alisha M Mendonsa; Joseph L Witztum; Ziqiang Guan; Christopher K Glass; Robert C Murphy; Edward A Dennis; Alfred H Merrill; David W Russell; Shankar Subramaniam; H Alex Brown
Journal:  J Lipid Res       Date:  2015-01-17       Impact factor: 5.922

5.  Comparative Proteomic Analysis of Human Liver Tissue and Isolated Hepatocytes with a Focus on Proteins Determining Drug Exposure.

Authors:  Anna Vildhede; Jacek R Wiśniewski; Agneta Norén; Maria Karlgren; Per Artursson
Journal:  J Proteome Res       Date:  2015-07-20       Impact factor: 4.466

6.  Mechanisms of amiodarone and valproic acid induced liver steatosis in mouse in vivo act as a template for other hepatotoxicity models.

Authors:  Alexa P Vitins; Anne S Kienhuis; Ewoud N Speksnijder; Marianne Roodbergen; Mirjam Luijten; Leo T M van der Ven
Journal:  Arch Toxicol       Date:  2014-02-18       Impact factor: 5.153

7.  MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights.

Authors:  Zhiqiang Pang; Jasmine Chong; Guangyan Zhou; David Anderson de Lima Morais; Le Chang; Michel Barrette; Carol Gauthier; Pierre-Étienne Jacques; Shuzhao Li; Jianguo Xia
Journal:  Nucleic Acids Res       Date:  2021-05-21       Impact factor: 16.971

8.  A cross-platform toolkit for mass spectrometry and proteomics.

Authors:  Matthew C Chambers; Brendan Maclean; Robert Burke; Dario Amodei; Daniel L Ruderman; Steffen Neumann; Laurent Gatto; Bernd Fischer; Brian Pratt; Jarrett Egertson; Katherine Hoff; Darren Kessner; Natalie Tasman; Nicholas Shulman; Barbara Frewen; Tahmina A Baker; Mi-Youn Brusniak; Christopher Paulse; David Creasy; Lisa Flashner; Kian Kani; Chris Moulding; Sean L Seymour; Lydia M Nuwaysir; Brent Lefebvre; Frank Kuhlmann; Joe Roark; Paape Rainer; Suckau Detlev; Tina Hemenway; Andreas Huhmer; James Langridge; Brian Connolly; Trey Chadick; Krisztina Holly; Josh Eckels; Eric W Deutsch; Robert L Moritz; Jonathan E Katz; David B Agus; Michael MacCoss; David L Tabb; Parag Mallick
Journal:  Nat Biotechnol       Date:  2012-10       Impact factor: 54.908

9.  Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects.

Authors:  D W L Ma; B M Arendt; L M Hillyer; S K Fung; I McGilvray; M Guindi; J P Allard
Journal:  Nutr Diabetes       Date:  2016-07-18       Impact factor: 5.097

Review 10.  Lipidomics in non-alcoholic fatty liver disease.

Authors:  Sofia Kartsoli; Christina E Kostara; Vasilis Tsimihodimos; Eleni T Bairaktari; Dimitrios K Christodoulou
Journal:  World J Hepatol       Date:  2020-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.